Redefining the criteria for ALK-positive lung cancer – Oncology Nurse Advisor

by lowes1 on September 26, 2013

Redefining the criteria for ALK-positive lung cancer
Oncology Nurse Advisor
The current criteria used to match lung cancers with the drug crizotinib may miss some patients who could benefit from the drug. Findings from a new study suggest that doctors should look closer at borderline or atypical anaplastic lymphoma kinase 

View full post on lung cancer – Google News

Leave a Comment

Previous post:

Next post: